Denver, CO 3/3/2008 11:34:51 PM
News / Health & Wellness

LegalView Reports Information about Asbestos Removal Falsified by School Official

LegalView.com recently updated the mesothelioma blog on its Mesothelioma information to bring readers a story about a school official who falsified records of asbestos removal at a school, thus endangering students and faculty. The official, who was a superintendent at the school, admitted to having filed the false reports about asbestos removal in a few of his schools including elementary schools.

Mesothelioma is a deadly form of lung cancer that is caused by the inhalation of asbestos fibers and dust. Asbestos is a mineral that was used in the construction of homes, schools, office buildings, commercial buildings, apartment complexes, government buildings and universities. It was also used in several additional construction applications such as in linoleum flooring. It was mined and used across the United States because of its resistance to heat, which makes for an ideal insulation in the construction industry. However, after years of mining asbestos, officials learned that it was deadly to breathe in asbestos particles and many buildings had to spend thousands of dollars to remove the asbestos, as required by the Environmental Protection Agency (EPA).

Mesothelioma cancer can take years to develop and many victims suffer from it without knowing they have mesothelioma. Additionally, the disease is quite often misdiagnosed among medical professionals and by the time it is diagnosed, the patient may face limited treatment options. If you or anyone you know may have come in contact with asbestos through an occupation or any additional way, it is extremely advisable to seek medical attention as well as to contact an experienced mesothelioma attorney to better understand how to develop a mesothelioma lawsuit, which could help receive monetary compensation for medical bills associated with this disease.

LegalView also offers information on other diseases and medical issues affecting millions of Americans each year including Nephrogenic Systemic Fibrosis (NSF) as well as information on the Duragesic Patch recall and the Trasylol recall. NSF is a very rare disease that causes a victim's skin to swell and form red sores. The skin not only swells but it begins to thicken and eventually harden debilitating a victim from everyday movements such as bending arms and knees. NSF's cause is not yet known but it has been linked with gadolinium dye administered during magnetic resonance imaging (MRI) and other medical procedures. Individuals who have been diagnosed with this illness should use LegalView's information portal to find an
NSF law firm in their area. The Duragesic patch is a pain-relieving patch that is used to treat patients with moderate to severe body pain. The patch releases low doses of a pain reliever over several hours. However, it has been recently been the subject of a Duragesic recall because of a manufacturing defect that is causing the pain medication to leak and patients to overdose. To learn more about the recall visit http://duragesic.legalview.com/.

Additionally, the injectable blood clotting drug, Trasylol, administered during medical procedures has been linked to an increase in kidney failure, heart attack, stroke and death among patients. Individuals who have recently been involved in a medical procedure and who were administered a Trasylol injection should contact an experienced law firm to learn about developing a
Trasylol lawsuit.

About LegalView:LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at
www.LegalView.com.